Changing depot medroxyprogesterone acetate access at a faith-based institution
Authors:
- Maryam GuiahiMGMaryam Guiahi
- Moira McNultyMMMoira McNulty
- Gretchen GarbeGGGretchen Garbe
- Sarah EdwardsSESarah Edwards
- Kimberly KentonKKKimberly Kenton
- 1 September 2011
- journal article
- Published by Elsevier in Contraception
- Vol. 84 (3) , 280-284
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding womenContraception, 2009
- Rates of Follow-up and Repeat Pregnancy in the 12 Months After First-Trimester Induced AbortionObstetrics & Gynecology, 2009
- Hormonal ContraceptionObstetrics & Gynecology, 2008
- Preventing Repeat Teen Pregnancy: Postpartum Depot Medroxyprogesterone Acetate, Oral Contraceptive Pills, or the Patch?Journal of Pediatric and Adolescent Gynecology, 2007
- Depot-medroxyprogesterone acetate injection (Depo-Provera®): a highly effective contraceptive option with proven long-term safetyContraception, 2003
- A village would be nice but …American Journal of Preventive Medicine, 2001
- Postpartum contraceptive use among adolescent mothersObstetrics & Gynecology, 2000
- Depot Medroxyprogesterone Acetate or Oral Contraception in Postpartum AdolescentsObstetrics & Gynecology, 1998
- Unintended Pregnancy in the United StatesFamily Planning Perspectives, 1998
- Resumption of ovulation post partumAmerican Journal of Obstetrics and Gynecology, 1968